Results 111 to 120 of about 7,571,911 (312)

Extremal values on the Kirchhoff index of the line graph of trees

open access: yesKuwait Journal of Science
The computation of resistance distance and the Kirchhoff index is a classical problem that has been extensively investigated by numerous mathematicians, physicists, and scientists. Consider a simple connected graph G with vertex set V(G) and edge set E(G)
doaj   +1 more source

Enhancement the Armor Shielding Properties of CF/epoxy Composite by Addition Nanoparticles of Magnetic Iron Oxide

open access: yesMATEC Web of Conferences, 2017
In the present investigation, we prepared two types of CF composites. The first prepared composite sample was CF/epoxy resin composite and the second was CF/epoxy resin / with a different weight ratio of magnetic iron oxide.
Fouda Hany, Ghith Khalid, Guo Lin
doaj   +1 more source

On degree resistance distance of cacti

open access: yesDiscrete Applied Mathematics, 2016
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Jia-Bao Liu   +3 more
openaire   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Resistance-Distance Sum Rules

open access: yesCroatica Chemica Acta, 2002
The Chemical potential for a novel intrinsic graph metric, the resistance distance, is briefly recalled, and then a number of »sum rules« for this metric are established. »Global« and »local« types of sum rules are identified. The sums in the »global« sum rules are graph invariants, and the sum rules provide inter-relations amongst different invariants,
openaire   +2 more sources

Tumor‐stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer

open access: yesFEBS Open Bio, EarlyView.
Chemoresistance in bladder cancer: Macrophage recruitment associated with CXCL1, CXCL5 and CXCL8 expression is characteristic of Gemcitabine/Cisplatin (Gem/Cis) Non‐Responder tumors (right side) while Responder tumors did not show substantial tumor‐stromal crosstalk (left side). All biological icons are attributed to Bioicons: carcinoma, cancerous‐cell‐
Sophie Leypold   +11 more
wiley   +1 more source

Long-Distance Communication and Signal Amplification in Systemic Acquired Resistance

open access: yesFrontiers in Plant Science, 2013
Systemic acquired resistance (SAR) is an inducible defense mechanism in plants that confers enhanced resistance against a variety of pathogens. SAR is activated in the uninfected systemic (distal) organs in response to a prior (primary) infection ...
Jyoti eShah, Jürgen eZeier
doaj   +1 more source

Home - About - Disclaimer - Privacy